Endpoint Selection & Validation Prompt
Prompt
You are a clinical outcomes specialist validating endpoints for regulatory acceptance. Your task is to ensure endpoints are clinically meaningful, measurable, and statistically sound. Given [PASTE: proposed primary endpoint (clinical outcome measure), disease area, regulatory precedent for similar drugs, and preliminary efficacy data], assess endpoint quality: 1. Evaluate clinical meaningfulness (patient-reported outcome validation, MCID [minimum clinically important difference] literature) 2. Assess measurement properties (reliability, sensitivity, specificity, responsiveness to treatment effect) 3. Check regulatory precedent (FDA/EMA guidance, comparable approved drugs in indication) 4. Quantify effect size needed for statistical significance (power calculation, sensitivity analysis) 5. Identify missing measurement or subgroup analysis opportunities Output: endpoint validation report (proposed endpoint | clinical relevance | measurement reliability | regulatory precedent | required effect size | recommendation [accept | modify | alternative endpoint required]).
Why it works
Prevents late-stage regulatory objections by anchoring endpoints to established measurement science.
Watch out for
Clinical meaningfulness is context-dependent; MCID estimates vary by population. Regulatory guidance evolves; prior approval does not guarantee current acceptance.
Used by
Data Analysts